Buparlisib is a small molecule which can act as a PI3K inhibitor (pan-Class I). It is provided as a powder.
This product acts on the following target types: Kinase, Cytoskeleton.
This product acts on the following biochemical pathways: AKT, PI3K, Proliferation, DNA synthesis, Cell cycle.
This product may be of interest in the following research areas and diseases: Cell migration, Cancer.
Please note that our chemical products are for research use only in a laboratory and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address.